FDA Announces Submission of Blood Establishment Registration and Product Listing Form for OMB Review

Summary

The Food and Drug Administration (FDA) has submitted a proposed information collection form, FDA 2830, for review and clearance under the Paperwork Reduction Act of 1995, as part of its ongoing efforts to regulate blood establishments and product listings.